¿ø¹ß¼º ÀÚ°¡¸é¿ª °ñ¼ö¼¶À¯Áõ 1¿¹
A Case of Primary Autoimmune Myelofibrosis

´ëÇѳ»°úÇÐȸÁö 2014³â 86±Ç 5È£ p.632 ~ p.636

ÀÓ¿µ¹Î(Lim Yeong-Min) - Â÷ÀÇ°úÇдëÇб³ ³»°úÇб³½Ç
¹ÚÄ¡¿µ(Park Chi-Young) - Â÷ÀÇ°úÇдëÇб³ ³»°úÇб³½Ç
È«¿øÁ¤(Hong Won-Jung) - Â÷ÀÇ°úÇдëÇб³ ³»°úÇб³½Ç
±è±¤ÀÏ(Kim Gwang-Il) - Â÷ÀÇ°úÇдëÇб³ º´¸®Çб³½Ç
Á¤¼Ò¿µ(Chong So-Young) - Â÷ÀÇ°úÇдëÇб³ ³»°úÇб³½Ç
¿Àµµ¿¬(Oh Do-Yeun) - Â÷ÀÇ°úÇдëÇб³ ³»°úÇб³½Ç

Abstract

Primary autoimmune myelofibrosis, the development of which is not preceded by a well-defined autoimmune disease, has recently been defined as a distinct clinicopathologic syndrome. We report herein a case of a 68-year-old woman who was diagnosed with primary autoimmune myelofibrosis and present a review of the literature. The patient manifested peripheral pancytopenia, was positive for autoantibodies, and developed myelofibrosis with no preceding autoimmune or hematologic disorders. Her condition was dramatically improved after administration of prednisolone.

Å°¿öµå

Primary autoimmune myelofibrosis, Leukoerythroblastosis, Prednisolone
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå